Paul Donovan Quotations

We believe we can close by the end of March.

We factored in the possibility of something like this happening. This news is manageable and does not alter our fundamental belief in Guidant's long-term potential, which is significant and very much intact.

We've reviewed the intellectual property issues and are comfortable proceeding with the transaction. We don't expect this issue to impact the transaction.

If successful, we would combine the resources of two of the leading innovators in cardiovascular medicine and would expand our footprint into cardiac rhythm management. The Guidant acquisition is a natural outgrowth of our strategy to further diversify our business and accelerate growth.

We're pleased to close this chapter, and put this matter behind us. We can now direct our full attention to developing our life-saving products and technologies.

I think there is a reasonable chance we will see another interest rate reduction before the cycle is over, but I don't think it is going to happen quite yet.

Rear-projection technologies will undoubtedly dominate from 50 in. onward. The incremental cost of making them bigger is much less and profit margins remain higher.

We continue to move forward with our due diligence with the goal of reaching a definitive agreement with Guidant.

We continue to move forward on our due diligence with the goal of reaching a definitive agreement with Guidant. I don't think we're going to have anything more to say right now.

We continue to expect to be in a position to sign a definitive agreement in the first two weeks of January.

We continue to believe our $72 proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time. We continue to move forward on our due diligence with the goal of reaching a definitive agreement with Guidant.

We continue to believe our $72 (per share) proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time. We continue to move forward on our due diligence with the goal of reaching a definitive agreement with Guidant.

We continue to believe our $72 (a share) proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time.

We believe this issue has no bearing on our proposed acquisition of Guidant. Unfortunately, threats of legal action are commonplace in our industry.

We will recommend changes designed to ensure that the final regulation preserves the fullest possible beneficiary access to innovative technologies and therapies.

We have brought a lot of companies into the Boston Scientific family and we have never been more confident or enthusiastic about the prospects for a merger.

We are seeing a belief that the Japanese economy is recovering. The Japanese are going to keep their money at home and overseas investors are going to put more to work in Japan.

We should have things re-stocked in a few weeks.

We believe our $72 proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time.

Unfortunately, I don't think this is an empty threat. The problem for Philips is they are in such commodity businesses at the moment and production costs are much lower in Asia.

What's happening is that consumers are worried about losing their jobs, and if consumers worry about losing their jobs, they spend less money -- so the economy slows down, so they lose their jobs -- it's a vicious circle.

That's important because the actual proper economic indicators are getting a bit behind the times in picking up the changes that are taking places,

It was a very good quarter. We beat Wall Street consensus estimates for revenue, and we believe we met them for earnings.

Tax revenues are going to be lower. Fewer people will have jobs, fewer people will pay income tax, more people get unemployment benefits, so government spending goes up.

The issues that we addressed in our commitments were not material ones. At the request of the commission we made a number of commitments in order to resolve potential antitrust issues, as did Abbott.

The U.K economy is in a stronger position than many European economies, and perhaps now is the time to pause for a bit,

The DVD recorder and games console market will be a much bigger driver than the PC market. A PC is fine for writing a movie or backing it up, but ultimately you want to play it on a DVD player.

The Easter holiday in Europe pushes the due date back a few days, but we still believe the Commission may conclude its review before that date, and our goal is still to close during the first week of April.

The main focus this week is what the beige book is saying about the consumer sector in the U.S. because the consumer is absolutely crucial to the performance of the US economy over the course of this year - and that of course means  the performance of the global economy.